VJOncology is committed to improving our service to you

ESMO 2018 | Treatment implications from highly selective patient selection in clinical trials

VJOncology is committed to improving our service to you

Frank Griesinger

Recruiting patients into clinical trials tends to be a highly selective process, according to Frank Griesinger, MD, PhD, of the University of Göttingen, Göttingen, Germany. Choosing a very specific and selected patient population would not translate well for the real world population, and in this insightful interview recorded at the European Society for Medical Oncology (ESMO) 2018 Congress, in Munich, Germany, Prof. Griesinger states that data from such studies would be misleading, having a knock-on effect on the development of effective treatments for patients.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter